Porton Pharma Solutions Ltd. (SHE:300363)
24.56
+0.97 (4.11%)
Sep 30, 2026, 3:04 PM CST
| Market Cap | 13.17B -0.7% |
| Revenue (ttm) | 3.59B +9.4% |
| Net Income | -154.92M |
| EPS | -0.29 |
| Shares Out | 536.27M |
| PE Ratio | n/a |
| Forward PE | 66.38 |
| Dividend | 0.09 (0.37%) |
| Ex-Dividend Date | May 12, 2026 |
| Volume | 22,739,981 |
| Open | 23.72 |
| Previous Close | 23.59 |
| Day's Range | 23.47 - 24.87 |
| 52-Week Range | 13.24 - 30.40 |
| Beta | 0.55 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 27, 2026 |